Is there any reason to expect hematologic abnormalities to be associated with Eosinophilic Fasciitis?
Hematologic problems have been appreciated in 10% to 15% of patients with EF.
Those described in a small number of patients include immune-mediated anemia and thrombocytopenia, aplastic anemia, myelodysplasia, and lymphoproliferative diseases (multiple myeloma, lymphoma).
These complications may occur at any time during the course of EF and do not correlate with the severity of disease.
